2型糖尿病相关因素与血清肝细胞生长因子水平关系探讨被引量：1

下载PDF

导出

摘要目的:探讨2型糖尿病(T2DM)患者血清肝细胞生长因子(HGF)变化状况和其血脂状况、血糖代谢控制状况、血压(BP)的高低、体重指数(BMI)的大小关系。方法:采用ELISA双抗体夹心法来测定T2DM患者60例及和血清健康者40例HGF水平进行比较,并且进行腰围、臀围、体质量的常规测定,同时又对空腹血糖、高密度脂蛋白胆固醇、糖化血红蛋白、低密度脂蛋白胆固醇、总胆固醇、甘油三酯、尿酸和尿微量白蛋白与肌酐比值(Alb/Cr)进行测定。结果:2型糖尿病患者血清HGF水平明显高于对照组(P<0.01);明显高于有血管病变的2型糖尿病患者血清肝细胞生长因子水平比较无血管病变的2型糖尿病患者显著增高(P<0.05);糖化血红蛋白、空腹血糖、收缩压、低密度脂蛋白胆固醇和血清HGF水平之间的是呈正比关系(即r=0.53,r=0.54,r=0.58,r=0.72,P值均<0.01);而高密度脂蛋白胆固醇和HGF水平之间是负相关(对应的系数为r=-0.53,P<0.01)。结论:T2DM患者血清HGF增高,血管病变的T2DM者增高更为显著;糖尿病血管病变严重程度完全可以用血清肝细胞生长因子作为指标来反映,同时血压、血糖、血脂等是影响血清肝细胞生长因子水平的重要因素。

作者杨生

机构地区中国医科大学附属盛京医院

出处《陕西医学杂志》 CAS 2012年第5期568-569,596,共3页 Shaanxi Medical Journal

基金辽宁省科委自然科学基金项目(No 20102269)

关键词糖尿病非胰岛素依赖型/诊断肝细胞生长因子/代谢血糖/代谢

分类号 R587.1 [医药卫生—内分泌]

引文网络
相关文献

参考文献5

1郑宝石,胡建国,何巍.肝细胞生长因子在内皮细胞与心血管疾病中的研究进展[J].广西医科大学学报,2007,24(6):978-980. 被引量：6
2Kuhlm ann CR,Schaefer CA,Fehsecke A,et al.A new signa lingmechanism of hepatocyte growth factor-induced endothelial prolif-eration[J].J Thromb Haemost,2005,3(9):2089-2095.
3Morishita R,Nakamura S,Nakamura Y,et al.Potential role of en-dothelium-specific growth factor,hepatocyte growth factor,an en-dothelial damage in diabetes mellitus[J].Diabetes,1997,46(7):138-148.
4Nakano N,Moriguchi A,Morishita R,et al.Role of angioten sin Ⅱin the regulation of a novel vascular modulator,hepato cyte growthfactor(HGF),in experimental hypertensive rats[J].Hypertension,1997,30(6):1448-1454.
5Wang M,Crisostomo PR,Herring C,et al.Human progenitorcells from bone maeeow or adipose tissue produce VEGF,HGF,Aand IGF-1 in response to TNF by a p38 MAPK-dependent echa-nism[J].Am J Physiol Regul Integr Comp Physiol,291(4):880-884.

二级参考文献20

1Michalopoulos G, Houck KA,Dolan ML,et al. Control of hepatocyte replication by two serum factors. Cancer Res,1984,44(10) : 4 414-4 419.
2Zamegar R, Michalopoulos G. Purification and biological characterization of human hepatopoiet in a polypeptide growth factor for hepatocytes. Cancer Res, 1989, 49: 3 314.
3Miyazawa K, Tsubouchi, Haka D,et al. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun, 1989,163 : 967-973.
4Bottaro DP,Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the c-met protooncogene product . Science, 1991,251(4995) : 802-804.
5Nakamura Y, Morishita R, Higaki J, et al. Expression of iocal hepatocyte growth factor system in vascular tissues. Biochem Biophys Res Commun, 1995,215:483-488.
6Ponzeto C, Zhen Z, Audero E; et al. Speciflc uncoupling of GRB2 form the Met receptor. J Biol Chem, 1996,271 (9) : 14 119.
7Nakamura Y,Morishita R, Higaki J, et al. Expression of local hepatocyte growth factor system in vascular tissues. Biochem Biophys Res Commun, 1995,215 : 483-488.
8Bussolino F, Renzo MF, Ziche M, et al. Hepatocyte growth factor is a potent angiogenic factorwhich stimulates endothelial cell motility and growth. J Cell Biol, 1992,119(3) : 629-641.
9Morishita R, Higaki J, Hayashi S, et al. Role of hepatocyte growth factor in endothelial regulation :prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphosdiesterase type 3 inhibitor. Diabe-tologia,1997,40:1 053-1 061.
10Masahiro R, Yoshiki S, Masamichi O, et al. Myocardial protective effect of human recombinant hepatocyte growth factor for prolonged heart graft preservation in rats. Transplantation,2004,78: 1 153-1 158.